Institute of Physiology (IPHYS) of the Czech Academy of Sciences (CAS) is leading research institution in the field of normal and pathological physiology.

The academic and educational endeavours of its experts, many of them internationally recognised, aim to enhance the fundamental knowledge on metabolism and heart and brain function, thus paving the way to novel diagnostic and therapeutic procedures required to tackle serious medical conditions in humans. These chiefly include stroke, ischemic heart disease, diabetes, inherited metabolic disorders and neurodegenerative diseases such as Alzheimer’s or epilepsy.

• Knowledge of scientists from the Institute of Physiology and their discoveries represent a theoretical basis for the development of new therapies. 
• Institute holds an important role in the education of students and current health care workers.
• Institute of Physiology is consisted of a number of scientific laboratories and service departments. Insitute use the top equipment for the research.
• There are a wide range of world-renowned experts who regularly gain recognition for their scientific work of major domestic and foreign awards.
• Institute´s scientists have worked and still are working on a major social and manager positions (eg. prof. Helena Illnerová - president of The Czech Academy of Sciences 2001 - 2005), including significant positions in the international scientific societies (eg. prof. Bohuslav Ošťádal - president of the International Academy of Cardiovascular Sciences)
• The Institute has been organizing the series of lectures and seminars (among others Bureš lectures series and the popularisation lectures The human body in health and disease). It annually announces a competition for the best publications with authors from IPHYS.
• The Institute has been successful in attracting research funding at both national and international level. It participates also in research projects in the centers of excellence and is the partner of excellence project BIOCEV carried out jointly with other Academy of Sciences’ institutes and Charles University in Prague.
• The Institute is the part of a Translational Research Project MediAim that is dedicated to the development of new therapeutic agents and strategies to fight certain serious noncommunicable diseases and selected viral diseases. It´s included three institutions: IKEM, IOCHB and IPHYS.
• The Institute is also a recipient of EU Structural Funds support.
• More information is available also at presentation institute´s brochure (2017).
• Facts and Figures